Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

BearDownAZ

Sep 28, 2022 04:20PM

Re: Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

BearDownAZ

Sep 28, 2022 04:22PM

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

in response to

Re: Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

BearDownAZ

posted on Sep 28, 2022 04:41PM

The CORAL Phase 3 High-Risk COVID-19 Outpatient Study is being replaced with the Phase 3 Study of apabetalone in PCC, (Post COVID-19 Conditions).

BOM2 Phase 3 would be totally separate from the above.

IMO ... Koo

3 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply